DARES FROM DRUG TRADE

Big Pharma made plenty of news this week. Amarin sued the Food & Drug Administration for violating the firm's First Amendment free speech rights in prohibiting promoting a drug for unapproved uses. Michael Carome, M.D. explores the public health implications in "Outrage of the month:  Industry Lawsuit Threatens FDA's Regulation of Drugs" posted at Public Citizen's Health Letter of June, 2015. LEARN MORE

Then text of the Trans-Pacific Partnership (TPP) was leaked that shows pharmaceutical and medical device companies would gain more power over public access to their products and stymie public health programs, including limiting Congressional reform of Medicare and lower drug costs.  Big Pharma could challenge decisions a government makes on which drugs are offered and rates of reimbursement. Deirdre Fulton reported on the situation in "Leaked Text Shows Big Pharmacy Bullies Using TPP To Undermine Global Health" posted at Common Dreams on 6-10-15. LEARN MORE   

Posted on June 11, 2015 and filed under health policy, Public good.